📊 New Article available #OpenAccess
📌Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
🔗 www.thelancet.com/journals/lan...
Sugammadex reduced the incidence of postoperative pulmonary complications or death
compared with neostigmine. The risk reduction was small with atelectasis of uncertain
clinical significance being the...